Summary
- Current Price
- As of today, GTBP price is $0.45, up +10.02% on
- Current Price All-Time High
- GTBP price is currently -99.97% below its historical high of $1,428.00 set on
- Market Cap
- GTBP current market cap is $12M, up +100.36% over the past 365 days
- PE Ratio
- GTBP PE ratio is unknown
- Revenue
- GTBP current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for GTBP has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | GT Biopharma, Inc. |
| Ticker | NASDAQ: GTBP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | gtbiopharma.com |
| Employees | 1 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.45 | ||
| Price, 1D Change | +10.02% | |
| $12M | ||
| - | ||
| - | ||
| 0.31 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$6.25 | ||
| EPS, 1Y Change | +9.93% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:30 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$6.25 | ||
| EPS Estimate | N/A | -$0.32 |
| EPS Est. Change | N/A | +94.88% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.45 | ||
| Price Target | - | $3.00 |
| Price Tgt. Change | - | +566.67% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$10.80 | -$6.94 | +35.77% | |
| -$1.66 | -$6.25 | -276.41% | |
| -$0.32 | N/A | +94.88% | |
| -$0.26 | N/A | +95.84% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -80.93% | ||
| -97.27% | ||
| +100.36% | ||
| -40.88% | ||
| 0.00% | ||
| 0.00% | ||
| +9.93% | ||
| +68.22% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.45 | ||
| $1.02 | ||
| SMA 200 vs Price | +127.56% | |
| $0.49 | ||
| SMA 50 vs Price | +9.60% | |
| 0.31 | ||
| $0.04 | ||
| 49.10 | ||
| 85.74% | ||
| 116.62% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $229.00K | ||
| -0.81% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$6.25 | ||
| $0.00 | ||
| - | ||
| -$12.42M | ||
| - | ||
| -$28.35M | ||
| - | ||
| -$12.42M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 3.22 | ||
| 3.22 | ||
| - | ||
| - | ||
| -126.22 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 2.07 | ||
| -0.41 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $5.79M | ||
| $6.91M | ||
| $8.11M | ||
| $7.47M | ||
| $2.32M | ||
| $2.32M | ||
| $0.00 | ||
| $0.00 | ||
| $748.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $28.35M | ||
| $12.42M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$12.91M | ||
| $0.00 | ||
| $15.78M | ||
| $0.00 | ||
| -$12.91M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Roth MKM | ||
| HC Wainwright & Co. | → | |
| EF Hutton | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| EF Hutton | → | |
| HC Wainwright & Co. | ||
| EF Hutton | ||
| EF Hutton | ||
| HC Wainwright & Co. |
Analyst sentiment
Institutional ownership
Screeners with GTBP
FAQ
What is the ticker symbol for GT Biopharma, Inc.?
The ticker symbol for GT Biopharma, Inc. is NASDAQ:GTBP
Does GT Biopharma, Inc. pay dividends?
No, GT Biopharma, Inc. does not pay dividends
What sector is GT Biopharma, Inc. in?
GT Biopharma, Inc. is in the Healthcare sector
What industry is GT Biopharma, Inc. in?
GT Biopharma, Inc. is in the Biotechnology industry
What country is GT Biopharma, Inc. based in?
GT Biopharma, Inc. is headquartered in United States
When did GT Biopharma, Inc. go public?
GT Biopharma, Inc. initial public offering (IPO) was on March 27, 2018
Is GT Biopharma, Inc. in the S&P 500?
No, GT Biopharma, Inc. is not included in the S&P 500 index
Is GT Biopharma, Inc. in the NASDAQ 100?
No, GT Biopharma, Inc. is not included in the NASDAQ 100 index
Is GT Biopharma, Inc. in the Dow Jones?
No, GT Biopharma, Inc. is not included in the Dow Jones index
When was GT Biopharma, Inc. last earnings report?
GT Biopharma, Inc.'s most recent earnings report was on May 13, 2024
When does GT Biopharma, Inc. report earnings?
The date for GT Biopharma, Inc.'s next earnings report has not been announced yet
Data Sources & References
- GTBP Official Website www.gtbiopharma.com
- GTBP Profile on Yahoo Finance finance.yahoo.com/quote/GTBP
- GTBP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gtbp